| Name | N-alpha-Tosyl-L-lysine chloromethyl ketone hydrochloride |
| Description | N-alpha-Tosyl-L-lysine chloromethyl ketone hydrochloride (N-alpha-Tosyl-L-lysine_chloromethyl_ketone_hydrochloride) is an inhibitor of trypsin-like protease and exhibits an inhibitory effect on IFN-γ activities. |
| In vitro | A lower concentration of anti-Fas (10 ng/mL) is used to examine the interaction among the three effectors simultaneously, that is, anti-Fas, TLCK, and IFN-γ. N-alpha-Tosyl-L-lysine chloromethyl ketone hydrochloride (50 μM) exhibits a small decrease in cell viability. Beyond 50 μM, a dose-dependent decrease in cell viability is observed. IFN-γ slightly reduces cell viability on its own. The addition of anti-Fas (10 ng/mL) results in a slight decrease in cell survival, which is enhanced more than additively in the presence of TLCK, most prominently between 50 and 100 μM. Upon addition of both anti-Fas and IFN-γ, a decrease (≈46%) in cell viability is observed. Moreover, the decrease in cell survival is further enhanced by the addition of higher concentrations of TLCK, 25 μM, and more[1]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | H2O : 95 mg/mL (257.24 mM), Sonication is recommended.
10% DMSO+40% PEG300+5% Tween 80+45% Saline : 5 mg/mL (13.54 mM), Sonication is recommended.
DMSO : 245 mg/mL (663.40 mM), Sonication is recommended.
|
| Keywords | Trypsin-like proteasomes | NalphaTosylLlysine chloromethyl ketone hydrochloride | N alpha Tosyl L lysine chloromethyl ketone hydrochloride | Inhibitor | inhibit | IFN-γ |
| Inhibitors Related | Acetaminophen | Deferiprone | Phenidone | Salicin | Gallic Acid Monohydrate | Diclofenac Potassium | Meloxicam | Paradol | Phenylbutazone | Glafenine | Minoxidil | Revaprazan hydrochloride |
| Related Compound Libraries | Nonsteroidal Anti-Inflammatory Compound Library | Pain-Related Compound Library | Bioactive Compound Library | Neuronal Signaling Compound Library | Cytokine Inhibitor Library | Ubiquitination Compound Library | Hematonosis Compound Library | Protease Inhibitor Library | Inhibitor Library | Immunology/Inflammation Compound Library | Anti-Aging Compound Library | Bioactive Compounds Library Max |
United States
